ACELYRIN (SLRN) Earnings Date & Reports

Acelyrin Inc is a late-stage clinical biopharmaceutical company... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

SLRN is expected to report earnings to rise 23.30% to -126 cents per share on June 12

Q1'25

Est.

$-1.27

Q4'24

Beat

by $0.38

Q3'24

Beat

by $0.70

Q2'24

Beat

by $0.22

Q1'24

Beat

by $0.65

The last earnings report on March 27 showed earnings per share of -102 cents, beating the estimate of -140 cents. With 195.57K shares outstanding, the current market capitalization sits at 235.66M.

View a ticker or compare two or three

Compare

SLRN

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For SLRN
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

4149 Liberty Canyon Road

Phone

+1 805 730-0360

Employees

130

Web

https://www.acelyrin.com